AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 crore in its first year, according to IQVIA data. The oncology drug’s ...
Bangalore: Syngene International Limited has announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the Board of Directors to pursue other opportunities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results